Yu Mingde: the policy of medical reform is changing in a good direction

Source: medical geography on November 26, 2014, the "2014 (third) pharmaceutical Strategy Summit" jointly sponsored by China Pharmaceutical Industry Information Center, China Pharmaceutical Enterprise Development Association, reed Pharma exhibition and 39 health.com was held in Guangzhou Tianhe new day Hilton Hotel Yu Mingde, President of China Pharmaceutical Enterprise Management Association, delivered a keynote speech on "new progress of medical reform policy" The policy environment we are particularly concerned about most needs a good policy environment for the development of medicine Good policies promote development, and a series of documents have played an important guiding role in creating a good policy environment for us At present, the policy of drug bidding and purchasing is our most problematic policy In order to reduce the false high drug price and avoid the vicious competition of low price, this is a very complete expression We are against the false high and false low For generic drugs that have reached the international level, support should be given in terms of pricing and bidding procurement If priority can be given to procurement, it will be better In GBF [2013] No 14 document, it is directly expressed as "priority procurement of generic drugs reaching international level", which is the guidance of the State Council The best procurement is not the lowest price Then, what about the lowest bidding? In the evaluation of commercial bidding, the drugs with obviously low bidding price should be comprehensively evaluated to avoid vicious competition There are also a series of documents that play an important guiding role in creating a good policy environment For example, some opinions on promoting the development of health service industry (GF [2013] No 40) put forward "government guidance", which used to be called "government guidance", that is, for the five aspects of the development of service industry, the government is not leading but guiding, the market allocates resources, and non forbidden access, which fully embodies the new ruling idea of the Party Central Committee since the 18th National Congress For another example, the latest document Guo Fa [2014] No 20 "opinions of the State Council on promoting fair competition in the market and maintaining normal market order" reflects the simplification of administration and decentralization The document states: "if it is not authorized by the law, the government departments cannot do it Release the price of competitive links; prohibit disguised examination and approval from setting up administrative license in the form of filing, registration, registration, annual inspection, supervision, identification, certification, examination, designation, allotment number, license change or in the name of non administrative license examination and approval; prohibit the implementation of disguised administrative examination and approval or illegal setting of charging items; It is strictly prohibited to turn the matters subject to administrative examination and approval into intermediary services, and engage in disguised examination and approval and paid services " General Secretary Xi said that "to let the people supervise power and let power run in the sun is a change strategy to put power in the institutional cage." This is a very pertinent sentence It should be like this Now it is far away from this We hope to put forward constructive suggestions to make the policy more perfect and optimized Five focus issues in the pharmaceutical industry are focused on centralized and unified bidding In 2014, a leader in Guangdong Province said, "hospitals are not satisfied, enterprises are not satisfied, patients are not satisfied, and government departments themselves are not satisfied." He said that since everyone is not satisfied with our work, why should we do it? The problem is very heavy, and I think it is a matter of interests in the end I think the problem of bidding is very big Some departments have also strived for establishment in order to consolidate their rights This is a wrong trend in recent years This is an obstacle to reform What the market needs is fairness and efficiency An argument about second bargaining We all have different opinions on the second negotiation We feel that there is no problem in the second negotiation Why can't the hospital as the Buyer negotiate? The key lies in the legality and rationality of the first negotiation Therefore, the key point of the second negotiation is "one", "one" is unreasonable and should be cancelled, "two" if reasonable, the hospital should be allowed to participate in its own procurement, which is the right of hospital operators About the right and wrong of hospital pharmacy trusteeship We have no objection to the trusteeship of the pharmacy, which is a direction originally and can be chosen But the leaders can't specify either In one case, a company entrusted 81 companies in less than a week, and was exposed by the media The legal person of the company said that it had a good relationship with the Secretary of the municipal Party committee, and the municipal Party committee of the 81 hospitals appointed them to be entrusted How can this be regarded as a fair competition in the market? So, the pharmacy "entrusted", "entrusted to whom", "how to entrust" Please respect the autonomy of the hospital legal person, and the power should be withdrawn from the operation Low price drug list is a major breakthrough in medical reform The list of low-cost drugs is of great significance It is followed by a supplementary list of low-cost drugs A large number of supplementary low-cost drugs have not been invited for bidding What a good thing, how much wealth the society has saved and more and more go to the market In this way, it will gradually reverse the government's misplaced bidding subject Internet drug trade - great change of drug administration This is the document with the most reform spirit First, because in the past, third-party distribution was not allowed Now, qualified third-party distribution can be opened, including confirmed non drug distribution institutions, such as Shunfeng, so it can be confirmed Second, it used to be OTC Now it's OTC plus some prescription drugs The policies of low-cost drug list and Internet transaction will greatly promote the development of our industry.